Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: A randomized, double-blind, crossover trial

Journal of Nutrition

Volumn 136, Issue 2, 2006, Pages 404-408

  Nielsen, Inge Lise F ^a   Chee, Winnie S S ^a   Poulsen, Lea ^b   Offord Cavin, Elizabeth ^a   Rasmussen, Salka E ^b   Frederiksen, Hanne ^b   Enslen, Marc ^a   Barron, Denis ^a   Horcajada, Marie Noelle ^c   Williamson, Gary ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c CEMAGREF   (France)

Author keywords

Bioavailability; Citrus antioxidant; Hesperetin 7 glucoside; Hesperidin; Randomized crossover study

Indexed keywords

AGLYCONE; FLAVONOID; GLUCOSIDE; HESPERIDIN; RHAMNOSE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD LEVEL; CITRUS FRUIT; CLINICAL TRIAL; COLON ABSORPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ENZYME ACTIVATION; ENZYME MODIFICATION; FEMALE; HUMAN; MALE; NORMAL HUMAN; NUTRIENT AVAILABILITY; NUTRIENT CONCENTRATION; NUTRIENT CONTENT; NUTRITIONAL HEALTH; ORANGE JUICE; RANDOMIZED CONTROLLED TRIAL; SMALL INTESTINE ABSORPTION;

CITRUS;

EID: 32444451694     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.2.404     Document Type: Article

References (27)

1. Hertog MG, Feskens EJ, Kromhout D. Antioxidant flavonols and coronary heart disease risk. [letter] Lancet. 1997;349:699.
2. Kroon P, Williamson G. Polyphenols: dietary components with established benefits to health? J Sci Food Agric. 2005;85:1239-40.
3. Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr. 2004;134:3479S-85.
4. Chiba H, Uehara M, Wu J, Wang X, Masuyama R, Suzuki K, Kanazawa K, Ishimi Y. Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr. 2003;133:1892-7.
5. Garg A, Garg S, Zaneveld LJ, Singla AK. Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother Res. 2001;15:655-69.
6. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002;76:560-8.
7. Erlund I, Meririnne E, Alfthan G, Aro A. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr. 2001;131:235-41.
8. Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C, Rémésy C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr. 2003;57:235-42.
9. Hollman PC, Bijsman MN, van Gameren Y, Cnossen EP, de Vries JH, Katan MB. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res. 1999;31:569-73.
10. Arts IC, Sesink AL, Faassen-Peters M, Hollman PC. The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides. Br J Nutr. 2004;91:841-7.
11. Erlund I, Kosonen T, Alfthan G, Maenpaa J, Perttunen K, Kenraali J, Parantainen J, Aro A. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol. 2000;56:545-53.
12. Morand C, Manach C, Crespy V, Rémésy C. Quercetin 3-O-beta-glucoside is better absorbed than other quercetin forms and is not present in rat plasma. Free Radic Res. 2000;33:667-76.
13. Olthof MR, Hollman PC, Vree TB, Katan MB. Bioavailabilities of quercetin-3-glucoside and quercetin-4′-glucoside do not differ in humans. J Nutr. 2000;130:1200-3.
14. Hollman PC, van Trijp JM, Buysman MN, van der Gaag MS, Mengelers MJ, de Vries JH, Katan MB. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett. 1997;418:152-6.
15. Gonzalez-Barrio R, Trindade LM, Manzanares P, De Graaff LH, Tomas-Barberan FA, Espin JC. Production of bioavailable flavonoid glucosides in fruit juices and green tea by use of fungal alpha-L-rhamnosidases. J Agric Food Chem. 2004;52:6136-42.
16. Nielsen SE, Freese R, Cornett C, Dragsted LO. Identification and quantification of flavonoids in human urine samples by column-switching liquid chromatography coupled to atmospheric pressure chemical ionization mass spectrometry. Anal Chem. 2000;72:1503-9.
17. Nielsen SE, Dragsted LO. Column-switching high-performance liquid chromatographic assay for the determination of quercetin in human urine with ultraviolet absorbance detection. J Chromatogr B Biomed Sci Appl. 1998;707:81-9.
18. Crespy V, Morand C, Besson C, Manach C, Demigné C, Rémésy C. Quercetin, but not its glycosides, is absorbed from the rat stomach. J Agric Food Chem. 2002;50:618-21.
19. Nemeth K, Plumb GW, Berrin JG, Juge N, Jacob R, Naim HY, Williamson G, Swallow DM, Kroon PA. Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr. 2003;42:29-42.
20. Day AJ, DuPont MS, Ridley S, Rhodes M, Rhodes MJ, Morgan MR, Williamson G. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett. 1998;436:71-5.
21. Gee JM, DuPont MS, Day AJ, Plumb GW, Williamson G, Johnson IT. Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. J Nutr. 2000;130:2765-71.
22. Bokkenheuser VD, Shackleton CH, Winter J. Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. Biochem J. 1987;248:953-6.
23. Day AJ, Canada FJ, Diaz JC, Kroon PA, Mclauchlan R, Faulds CB, Plumb GW, Morgan MR, Williamson G. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett. 2000;468:166-70.
24. Day AJ, Gee JM, DuPont MS, Johnson IT, Williamson G. Absorption of quercetin-3-glucoside and quercetin-4′-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem Pharmacol. 2003;65:1199-206.
25. Graefe EU, Wittig J, Mueller S, Riethling AK, Uehleke B, Drewelow B, Pforte H, Jacobasch G, Derendorf H, Veit M. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol. 2001;41:492-9.
26. Morand C, Manach C, Crespy V, Rémésy C. Respective bioavailability of quercetin aglycone and its glycosides in a rat model. Biofactors. 2000;12:169-74.
27. Felgines C, Texier O, Morand C, Manach C, Scalbert A, Regerat F, Rémésy C. Bioavailability of the flavanone naringenin and its glycosides in rats. Am J Physiol Gastrointest Liver Physiol. 2000;279:G1148-54.